5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalic acid, 95.0%, 10g

3-(1-Methyl-1H-pyrazol-5-yl)isoxazol-5-amine, 98%, 1g

8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXYLIC ACID, 2-(AMINOMETHYL)-, 1,1-DIMETHYLETHYL ESTER, 95%, 1g

Methyl 2-Iodo-3-nitrobenzoate, 97.0%, 25g

Filtration unit Stericup® with Durapore® (PVDF) membrane Pore size 0.22 μm, 500 ml, 1000 ml, 12 Piece(s)

1,3-Diisopropylbenzene>96.0%(GC)25mL

tert-Butyl 2,5-diazabicyclo[4.1.0]heptane-2-carboxylate, 97%, 5g

3-(4-chloro-3-methylphenyl)propanoic acid, 95.0%, 250mg

(R)-5-(TERT-BUTOXYCARBONYL)-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID, 95.0%, 1g

N-[1-(1H-1,2,3-Benzotriazol-1-yl)-2-methylpropyl]-4-methylbenzene-1-sulfonamide, tech, 50mg

(3-Chloro-4-((2-chlorobenzyl)oxy)phenyl)boronic acid, 95%, 5g

5-Amino-6-chloroquinoline, 95.0%, 2.5g

2-Chloropyridine-4-carbonyl chloride, 95.0%, 1g